My bet is that CF33 will obtain breakthrough therapy status from the FDA at some stage and we'll get to fastrack and miss out on expensive and timely phase 3 registrational studies.
Hence why we are buying IP to complement CF33, manufacturing facilities and staff.
IMU gearing up to be a pharmaceutical company, not just a research company.
Imo dyor.
Ann: Imugene Licenses Allogeneic CD19 CAR T Cell Therapy, page-57
-
- There are more pages in this discussion • 450 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 391333 | 6.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 1055 | 1 |
View Market Depth
| Last trade - 09.42am 12/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
Day chart unavailable